Galcanezumab treatment changes visual related EEG connectivity patterns in migraine patients.

Marianna La RoccaAnna LaportaLivio ClementeElena AmmendolaMarianna Diletta DelussiKatia RicciGiusy TancrediSebastiano StramagliaMarina de Tommaso

Published in: Cephalalgia : an international journal of headache (2023)

The potent anti-nociceptive action that galcanezumab exerts at a peripheral level could restore cortical connections and possibly factors predisposing to attack onset.

Keyphrases

end stage renal disease
resting state
ejection fraction
functional connectivity
newly diagnosed
chronic kidney disease
multiple sclerosis
white matter
neuropathic pain
anti inflammatory
combination therapy